We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Gas Analyzers Have New Compliance Capabilities

By LabMedica International staff writers
Posted on 23 Jan 2011
Blood gas analyzers have been enhanced and redesigned for low-to-mid- volume hospital and reference laboratories.

Quality Control (QC) information can be scanned into the system using simple barcode technology, increasing convenience for operators and minimizing opportunity for error. More...
The new applications conform specifically to the Guidelines of the German Federal Medical Council (RiliBAK) rules and Analytical Measurement Ranges, which helps to simplify the regulatory compliance process in select areas of the world.

The new enhancements are found on the RAPIDPoint 340/350 Blood Gas Analyzers enabling users to scan all quality control lot numbers and corresponding mean and standard deviation limits into the analyzer prior to running the ampouled QC. As quality control samples are analyzed, QC results for up to three levels per day, for a total of 31 days, are stored in the appropriate quality control folder on the instrument.

The RAPIDPoint 300 system produced by Siemens Healthcare Diagnostics, (Deerfield, IL, USA), can be configured so that the analytical measurement ranges for each parameter ensuring that patient results are provided only for values that have been validated according to the calibration verification material tested. A new faster and quieter printer completes the package of convenient features

David Stein, PhD, CEO, Point-of-Care Business Unit, Siemens Healthcare Diagnostics, said, "As hospital workloads increase, it is important to continually improve laboratory efficiencies and processes particularly in light of the cost containment and staffing challenges clinical laboratories face today. These latest enhancements to our blood gas systems were designed with that goal in mind."

Related Links:
Siemens Healthcare Diagnostics


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.